New Acoustofluidic Saliva Exosome Liquid Biopsy For Human Papilloma Virus 16

Unfortunately, cancers that occur in the back of the mouth and upper throat are often not diagnosed until they become advanced, partly because their location makes them difficult to see during routine clinical exams. A report in...

NanoString Grants Exclusive Global License To Veracyte For Diagnostic Use Of The nCounter® Platform

Veracyte has executed a definitive agreement with NanoString for the exclusive global license to the nCounter® platform for diagnostic use. The strategic transaction positions Veracyte to expand its genomic diagnostics business globally, with the ability to deliver its advanced genomic...

Eliminating Helicobacter Pylori Reduced Risk Of Gastric Cancer By 75% In An American Population

In a new study published in the journal Gastroenterology, researchers in the Perelman School of Medicine at the University of Pennsylvania have found, after analyzing records of close to 400,000 patients, that successfully eliminating Helicobacter pylori from...

Centogene And PTC Therapeutics Collaborate To Deliver A Diagnostic Program For AADC Deficiency

CENTOGENE N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, has signed an agreement with PTC Therapeutics, Inc. (PTC) for a global diagnostic program for aromatic...
CSF Biomarkers may help diagnose patients with neurological diseases

Biobanking Science: CSF Biomarkers for Neurological Diseases

Biobanks can help in the search for biomarkers to diagnose brain diseases. Neurological diseases can be difficult to diagnose as they may have overlapping symptoms. Furthermore, there are currently no diagnostic tests for diseases such as Amylotrophic lateral sclerosis...

ALS Biomarker Study At Massachusetts General Sponsored By Mitsubishi Tanabe Pharma America

Mitsubishi Tanabe Pharma America, Inc. (MTPA) has announced a collaboration with the Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI) to conduct a study designed to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis (ALS).
Traumatic brain injury can increase the risk of neurodegenerative diseases.

Biobanking Science: Biomarkers for Traumatic Brain Injury

Traumatic brain injury has been in the news lately because even mild traumatic brain injury, or concussion, can increase the risk of developing neurodegenerative diseases like Parkinson’s disease (1). Many parents have understandably been worried about their children suffering...

🔥 Most Popular



Featured Vendors
X